Clinical Trial Update: Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer

View source ↗

Summary

A clinical trial update studying gender-based differences in the safety and efficacy of lenvatinib for differentiated thyroid cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Differentiated Thyroid Cancer, Gender | Status: RECRUITING